key: cord-0020540-5upz24yo
authors: Shi, Chunhu; Dumville, Jo C; Cullum, Nicky; Connaughton, Emma; Norman, Gill
title: Compression bandages or stockings versus no compression for treating venous leg ulcers
date: 2021-07-26
journal: Cochrane Database Syst Rev
DOI: 10.1002/14651858.cd013397.pub2
sha: 4ade8e4bd3d8b5e76f1c50a63cbddc569f2586ee
doc_id: 20540
cord_uid: 5upz24yo

BACKGROUND: Leg ulcers are open skin wounds on the lower leg that can last weeks, months or even years. Most leg ulcers are the result of venous diseases. First‐line treatment options often include the use of compression bandages or stockings. OBJECTIVES: To assess the effects of using compression bandages or stockings, compared with no compression, on the healing of venous leg ulcers in any setting and population. SEARCH METHODS: In June 2020 we searched the Cochrane Wounds Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), Ovid MEDLINE (including In‐Process & Other Non‐Indexed Citations), Ovid Embase and EBSCO CINAHL Plus. We also searched clinical trials registries for ongoing and unpublished studies, and scanned reference lists of relevant included studies as well as reviews, meta‐analyses and health technology reports to identify additional studies. There were no restrictions by language, date of publication or study setting. SELECTION CRITERIA: We included randomised controlled trials that compared any types of compression bandages or stockings with no compression in participants with venous leg ulcers in any setting. DATA COLLECTION AND ANALYSIS: At least two review authors independently assessed studies using predetermined inclusion criteria. We carried out data extraction, and risk‐of‐bias assessment using the Cochrane risk‐of‐bias tool. We assessed the certainty of the evidence according to GRADE methodology. MAIN RESULTS: We included 14 studies (1391 participants) in the review. Most studies were small (median study sample size: 51 participants). Participants were recruited from acute‐care settings, outpatient settings and community settings, and a large proportion (65.9%; 917/1391) of participants had a confirmed history or clinical evidence of chronic venous disease, a confirmed cause of chronic venous insufficiency, or an ankle pressure/brachial pressure ratio of greater than 0.8 or 0.9. The average age of participants ranged from 58.0 to 76.5 years (median: 70.1 years). The average duration of their leg ulcers ranged from 9.0 weeks to 31.6 months (median: 22.0 months), and a large proportion of participants (64.8%; 901/1391) had ulcers with an area between 5 and 20 cm(2). Studies had a median follow‐up of 12 weeks. Compression bandages or stockings applied included short‐stretch bandage, four‐layer compression bandage, and Unna's boot (a type of inelastic gauze bandage impregnated with zinc oxide), and comparator groups used included 'usual care', pharmacological treatment, a variety of dressings, and a variety of treatments where some participants received compression (but it was not the norm). Of the 14 included studies, 10 (71.4%) presented findings which we consider to be at high overall risk of bias. Primary outcomes There is moderate‐certainty evidence (downgraded once for risk of bias) (1) that there is probably a shorter time to complete healing of venous leg ulcers in people wearing compression bandages or stockings compared with those not wearing compression (pooled hazard ratio for time‐to‐complete healing 2.17, 95% confidence interval (CI) 1.52 to 3.10; I(2) = 59%; 5 studies, 733 participants); and (2) that people treated using compression bandages or stockings are more likely to experience complete ulcer healing within 12 months compared with people with no compression (10 studies, 1215 participants): risk ratio for complete healing 1.77, 95% CI 1.41 to 2.21; I(2) = 65% (8 studies with analysable data, 1120 participants); synthesis without meta‐analysis suggests more completely‐healed ulcers in compression bandages or stockings than in no compression (2 studies without analysable data, 95 participants). It is uncertain whether there is any difference in rates of adverse events between using compression bandages or stockings and no compression (very low‐certainty evidence; 3 studies, 585 participants). Secondary outcomes Moderate‐certainty evidence suggests that people using compression bandages or stockings probably have a lower mean pain score than those not using compression (four studies with 859 participants and another study with 69 ulcers): pooled mean difference −1.39, 95% CI −1.79 to −0.98; I(2) = 65% (two studies with 426 participants and another study with 69 ulcers having analysable data); synthesis without meta‐analysis suggests a reduction in leg ulcer pain in compression bandages or stockings, compared with no compression (two studies without analysable data, 433 participants). Compression bandages or stockings versus no compression may improve disease‐specific quality of life, but not all aspects of general health status during the follow‐up of 12 weeks to 12 months (four studies with 859 participants; low‐certainty evidence). It is uncertain if the use of compression bandages or stockings is more cost‐effective than not using them (three studies with 486 participants; very low‐certainty evidence). AUTHORS' CONCLUSIONS: If using compression bandages or stockings, people with venous leg ulcers probably experience complete wound healing more quickly, and more people have wounds completely healed. The use of compression bandages or stockings probably reduces pain and may improve disease‐specific quality of life. There is uncertainty about adverse effects, and cost effectiveness. Future research should focus on comparing alternative bandages and stockings with the primary endpoint of time to complete wound healing alongside adverse events including pain score, and health‐related quality of life, and should incorporate cost‐effectiveness analysis where possible. Future studies should adhere to international standards of trial conduct and reporting.

There is probably a shorter time to complete healing of venous leg ulcers in people wearing compression bandages or stockings compared with those not wearing compression Proportion of wounds completely healed during follow-up follow up: range 1 day to 12 months 8 studies (1120 participants) with analysable data: RR 1.77 (95% CI 1.41 to 2.21) Two studies (95 participants) without analysable data: 1 study reported 71% of leg ulcers completely healed in short-stretch bandages and 25% in usual care. 1 study reported 82% of 21 participants with ulcers healed when using compression plus local povidone-iodine (Betadine) and 62% of 21 participants with ulcers healed when using local povidone-iodine (Betadine) 1215 (10 RCTs)

People treated with compression bandages or stockings probably have more completely healed venous leg ulcers during follow-up to 12 months than people not in compression Adverse events follow-up: range 8 weeks to 12 months 3 studies (585 participants) with adverse event data that were systematically collected: RR 0.98 (95% CI 0.25 to 3.80) a

⊕⊝⊝⊝ Very low d,e,f It is uncertain whether there is any difference in the risk of adverse events associated with using compression and not using compression Participant health-related quality of life/ health status follow-up: 12 weeks to 12 months Two studies (426 participants): pooled MD in the total score of the Charing Cross Venous Ulcer Questionnaire (lower scores = better quality of life) −6.87 (95% CI −13.10 to −0.64) between using compression bandages or stockings and no compression, but data analysis showed no difference in the physical component, mental component, and functional status of the SF-12.

(4 RCTs) ⊕⊕⊝⊝ Low g Compression bandages or stockings may improve participant health-related quality of life for some (but not all) aspects during the follow-up of 12 weeks to 12 months Two studies without analysable data (433 participants): 1 study (233 participants) stated that, for most dimensions of the SF-36 and EuroQol, health status deteriorated over time but was not different between 4-layer bandages and usual care. 1 study (200 participants) reported a statistical difference in some dimensions of the SF-36 (including physical function, role-physical, mental health) and the disease-specific quality of life instrument for chronic lower limb venous insufficiency (CIVIQ) (physical, social, and global dimensions) but not in others in comparison with no compression Cost effectiveness follow-up: 12 weeks and 12 months Two studies without incremental mean cost per incremental gain in benefit: 1 study (53 participants) reported that the short-stretch bandage was more cost-effective than usual care as it could be washed and reused repeatedly. 1 study (200 participants) showed that the median cost per leg healed was significantly less for 4-layer bandages than dressings (P = 0.04).

1 study (233 participants) with incremental mean cost per incremental gain in benefit: incremental cost-effectiveness ratio = GBP 2.46 (95% CI −31.94 to 99.12) per ulcer-free week between 4-layer bandage in leg ulcer clinics and no compression 486 (3 RCTs) ⊕⊝⊝⊝ Very low h,i,j It is uncertain whether compression bandages or stockings are cost effective compared with no compression in wound healing Mean pain score median follow-up period 12 weeks (minimum 12 weeks maximum 12 months)

Two studies with 426 participants and another study with 69 ulcers reported analysable data, with pain measured by either a 10-point visual analogue scale or a scale with grades from 1 to 10: pooled MD −1.39 (95% CI −1.79 to −0.98).

Two studies without analysable data (433 participants), neither reported the range of scales used: 1 study (233 participants) stated that people treated with 4-layer bandages were more likely to experience a reduction in leg ulcer pain per month than those using usual care; and another study (200 participants) reported a lower median of pain scores among those using 4-layer bandages than those using dressings (median 18.8, IQR 6.3 to 37.5; and 31.3, 18.8 to 43 .8, respectively; P = 0.14).

The use of compression probably reduces mean pain score compared with no compression.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; HR: Hazard Ratio; IQR: interquartile range; MD: mean difference; RCT: randomised controlled trial; RR: Risk ratio Library Trusted evidence. Informed decisions. Better health.

Cochrane Database of Systematic Reviews a One included study (84 participants with 87 ulcers) in these analyses reported clustered data whilst the other studies reported data by participant; the absolute e ect could not be estimated directly. b Downgraded once for risk of bias (one study with clustered data and another small study were at high overall risk of bias in domains other than performance bias, and the other three studies with most of the data in this synthesis were at unclear overall risk of bias). c Downgraded once for risk of bias (six studies having 569/1215 (46.8%) participants were at high risk of bias in the domains other than performance bias and the other four were at unclear risk of bias in some but not all domains). d Downgraded once for risk of bias (two studies with the larger numbers of participants were at high risk of bias in some domains and one study contributing 30.6% weight was at unclear risk of bias). e Downgraded twice for substantial inconsistency as the clustered data were inconsistent with the data reported by participant. f Downgraded once for imprecision because the CIs appeared to include the possibility of both benefit and harm as well as no e ect. g Downgraded twice for substantial inconsistency due to the variation of the reported results, particularly in terms of health status. h Downgraded once for risk of bias (one small study was at high overall risk of bias in domains other than performance bias and the other two studies were at unclear risk of bias in some domains). i Downgraded once for indirectness (results from two studies did not appear to be expressed as incremental mean cost per incremental gain in benefit). j Downgraded once for inconsistency in terms of cost-e ectiveness results between studies. k Downgraded once for risk of bias as two (of all six included) studies with 345 participants (a small proportion) were at high overall risk of bias.

Leg ulcers are open skin wounds on the lower leg (typically below the knee and mainly above the ankle) that can last weeks, months or even years. They occur as a consequence of arterial or venous insu iciency, or both. Less frequently, chronic leg ulceration may occur due to some other disease, such as rheumatoid disease or rarer conditions (Bafaraj 2014) . Most leg ulcers are the result of venous disease (Jockenhöfer 2014) , where blood flow in the veins is impaired by vein damage, obstruction and calf muscle pump failure (Eberhardt 2014). These problems mean that blood no longer returns e iciently from the legs to the heart and the pressure within the veins rises (Ghauri 2010). The precise chain of events that links high venous pressures with skin breakdown and subsequent chronic wounds is not fully understood.

Leg ulcers of mixed aetiology (those that have more than one cause) usually involve a combination of venous and arterial disease. Open skin ulceration that is due solely to limb ischaemia (a lack of oxygen reaching the leg tissues, i.e. arterial disease) is less common.

Current, accurate estimates of the proportion of leg ulcers due to specific aetiologies can be hard to identify because most studies do not di erentiate between venous, arterial or mixed aetiologies of leg ulceration, or do so for each limb but not for each person (Mo att 2004; Srinivasaiah 2007; Vowden 2009a) . Two pointprevalence surveys undertaken in the north of England estimated that venous ulceration has a prevalence of approximately 0.30 cases per 1000 population in the UK (Cullum 2016; Gray 2018) , whilst mixed arterial/venous leg ulceration has a prevalence of 0.11 per 1000 (Cullum 2016) . A review of studies of the prevalence of complex wounds suggests that there are limited high-quality data for estimating the burden of venous leg ulceration in lower-and middle-income countries (Cullum 2016) .

A di erential diagnosis of the underlying aetiology of a specific leg ulcer is made by taking a clinical history, physical examination, laboratory tests and other assessments (SIGN 2010) . Typically, the latter includes an assessment of the arterial blood supply to the leg using the ankle-brachial pressure index (ABPI), measured using a hand-held Doppler ultrasound scanner.

Leg ulcers are associated with considerable cost to patients and to healthcare providers. Two systematic reviews summarised the literature on health-related quality of life in people with leg ulcers (Herber 2007; Persoon 2004) . Both included qualitative and quantitative evaluations and reported that the presence of leg ulceration was associated with pain, restriction of work and leisure activities, impaired mobility, sleep disturbance, reduced psychological well-being and social isolation. Recent research suggests that people with complex wounds, including those with venous leg ulcers, commonly see complete wound healing as their most desirable outcome (Cullum 2016) . Leg ulceration is typically a long-term condition, with periods of healing followed by recurrence stretching over years.

The financial cost of treating a person with an open venous leg ulcer in the UK was estimated at approximately GBP 1700 per year at 2012 prices (Ashby 2014). Nursing time comprises a large part of ulcer treatment costs. A study in Bradford, UK (population approximately 500,000) estimated that for the financial year 2006 to 2007, GBP 1.69 million was spent on dressings and compression bandages, and GBP 3.08 million was spent on nursing time (estimates derived from resource-use data for all wound types, not just venous leg ulcers) (Vowden 2009b) . In the USA the estimated healthcare cost for people with venous leg ulcers was USD 14.9 billion (2012 prices, all payers including Medicare, private, self-insured) (Rice 2014). In four community wound-care clinics in Queensland, Australia, the mean weekly cost for each patient with a venous leg ulcer was estimated as AUD 294.72 at 2016/2017 prices for those receiving guideline-based care (i.e. with at least one ABPI and compression therapy) (Barnsbee 2019).

The first-line treatment for venous leg ulcers is compression therapy in the form of bandages, stockings or other devices (Partsch 2015) . This application of external pressure around the lower leg assists venous return (blood flow back to the heart) and reduces venous reflux. This review focuses on the e ects of compression delivered by bandages and stockings compared with no compression.

Bandages are categorised as retention, support or compression, depending on their performance in standardised laboratory tests. Compression bandages are further divided according to the amount of force required to extend them and therefore the level of compression that they can apply to a limb. Furthermore, the laboratory performance of a bandage may not reflect its performance in clinical use, as this depends upon operator training and application technique (specifically, whether the bandage is applied as a spiral or figure-of-eight, how many layers are applied and the amount of extension used). Compression systems commonly used for venous leg ulcers are listed below (Thomas 1995) .

• Class 3a: light-compression bandages; apply 14 mmHg to 17 mmHg pressure at the ankle when applied in a simple spiral, e.g. Elset (Mölnlycke). • Class 3b: moderate-compression bandages; apply 18 mmHg to 24 mmHg pressure at the ankle when applied as a simple spiral, e.g. Velkomp (Datt Mediproducts Pvt. Limited). • Class 3c: high-compression bandages; apply 25 mmHg to 35 mmHg pressure at the ankle when applied as a simple spiral, e.g. Setopress (Mölnlycke), and Elodur forte (BSN Medical). • Class 3d: extra-high-compression bandages; apply up to 60 mmHg pressure at the ankle when applied as a simple spiral.

In 2008 a new compression bandage classification system was proposed, based on components rather than the number of 'layers' of bandage (Partsch 2008) . The Partsch group recommended that the components of compression, such as orthopaedic wool, crepe bandage or cohesive elastic bandage, should be described.

Other recommended classification criteria included sub-bandage pressure (measured in the medial gaiter area with the patient supine) and the elastic property of the overall compression system. The following are examples of multi-component bandage systems (listed for illustrative purposes only; not intended as practice recommendations).

• Short stretch/inelastic systems: orthopaedic padding plus one or two rolls of short stretch bandage (SSB). • Inelastic paste systems: paste bandage plus support bandage, e.g. Setocrepe (Mölnlycke). • Two-component bandage systems: orthopaedic padding plus elastic bandage, e.g. 3M TM Coban TM 2 Compression System. • Four-component bandage systems: orthopaedic padding plus support bandage (crepe) plus class 3a bandage, e.g. PROFORE TM compression system (Smith & Nephew) .

The earliest Cochrane Review of compression for venous leg ulcers (Cullum 2001) defined di erent compression systems by the number of layers whereas, in line with the recommendations of the consensus group outlined above, subsequent versions refer to components. Nonetheless, where a trial treatment is the original Charing Cross four-layer bandage, or a close variant of it, we have continued to use the term 'four-layer bandage' (4LB), as this is an internationally-recognised bandage system.

It is more di icult to classify di erent compression systems in relation to sub-bandage pressures since, in general, this information is not available from clinical trial reports. In order to gain further insights into the optimal way to classify di erent compression systems, we consulted with experts in wound management and invited them to complete a survey (informing the previous update of this review) (O'Meara 2012). The survey listed di erent types of compression against various classifications, and respondents were asked to provide the best choice of classification in their opinion. In addition, free-text comments were invited. We used the information gleaned from this exercise to classify di erent types of compression therapy for the previous update of this review (O'Meara 2012).

Compression stockings (or hosiery) can be used to treat open ulcers and to reduce the risk of recurrence post-healing. Stockings are classified according to the level of compression they apply to the limb. Importantly, the pressure applied by stockings is subject to less operator variability than bandages.

• Class 1: light-support stockings; provide 14 mmHg to 17 mmHg pressure at the ankle. Used to treat varicose veins. • Class 2: medium-support stockings; provide 18 mmHg to 24 mmHg pressure at the ankle. Used to treat more severe varicosities, and to prevent venous leg ulcers. • Class 3: strong-support stockings; provide 25 mmHg to 35 mmHg pressure at the ankle. Used to treat severe chronic hypertension and severe varicose veins, and to prevent venous leg ulcers.

Alongside compression, wound dressings are almost always applied to open ulcers. Dressings protect the surface of the ulcer, absorb exudate and can be antimicrobial. A series of reviews has addressed the comparative e ectiveness of dressings for venous ulcers (Norman 2018; O'Meara 2013; O'Meara 2015) . Other treatments for venous leg ulcers include venous surgery (removal of incompetent superficial veins (Gohel 2018)) and drugs such as pentoxifylline (Jull 2012).

Generally, compression therapy is thought to work by applying an external pressure to the leg which assists venous return (blood flow back to the heart) and reduces venous reflux (Woo 2013) . Partsch has suggested that compression:

• reduces oedema by reducing capillary filtration, moving fluid from compressed tissues to non-compressed tissues and improving lymphatic drainage (Partsch 2011); and • reduces the pressure in the veins by increasing venous blood flow and reducing venous pooling (Partsch 2011).

The use of compression to treat venous leg ulcers is not without risk. Whilst Mosti 2012 has suggested that compression may increase arterial inflow, if the applied pressure exceeds the local arterial perfusion pressure then arterial inflow will be reduced, which risks ischaemia.

National clinical guidelines in the UK and USA recommend that all people presenting with a leg ulcer be screened for arterial disease using Doppler-aided measurement of the ABPI (Bolton 2014; SIGN 2010). Clinically significant arterial disease is o en defined as an ABPI of below 0.8. People with venous leg ulceration who have an ABPI of between 0.5 and 0.8 may be eligible to receive modified (reduced) compression (Mo att 2007).

Venous leg ulcers have a large impact on people's lives and incur high costs to health services; compression therapy is currently the first-line treatment. Since the publication of the original Cochrane Review of compression bandages and stockings for venous leg ulcers (Cullum 2001) , the number of relevant randomised controlled trials (RCTs) has more than doubled, the range of compression modalities has increased, and the classification of compression modalities has been refined. We update the evidence from the review (O'Meara 2012) in order to o er up-to-date evidence for decision-makers, and have decided to break down the previous version into separate reviews by compression modality. We will then review all compression modalities together in an overview, which will incorporate a network meta-analysis (Salanti 2012) , in order to rank the di erent treatments on their individual probabilities of being the most e ective compression modalities for healing venous leg ulcers. This particular review provides evidence about the comparison of compression bandages or stockings versus no compression.

To assess the e ects of using compression bandages or stockings, compared with no compression, on the healing of venous leg ulcers in any setting and any population.

We included published and unpublished RCTs, including cluster-RCTs and cross-over trials, irrespective of language of report. We excluded studies which used quasi-randomised methods to allocate treatment (e.g. alternation or odd/even case numbers). We included trials if the application of compression was the only systematic di erence between study arms.

We included randomised controlled trials which recruited people of any age with venous leg ulceration (which may also be described as 'stasis' or 'varicose' ulceration) in any care setting. As the method of diagnosis of venous ulceration could vary between studies, we applied no standardised definition, but each study had to refer to the use of compression for venous ulcers.

We included studies that recruited participants with a variety of wound types, including venous leg ulcers, if: a) the allocation of participants was stratified by wound type and included 'venous leg ulcer' as a group and results were presented (or available from the study authors) separately for this group; or b) studies included participants with non-venous leg ulcers, but these made up a maximum of 25% of the total study population and we assumed that any treatment e ect applied to people with venous ulcers. We excluded RCTs which only recruited people with non-venous leg ulcers (e.g. arterial, or mixed) from the review.

We included trials which compared the use of any compression bandage or stocking or any combination of compression with no compression (e.g. standard care, simple retention bandages, dressings alone) in participants with venous leg ulcers. We excluded trials where intermittent pneumatic compression was the mode of compression being evaluated, as this is the focus of another Cochrane Review (Nelson 2014).

We grouped outcome data using the following time categories; we used our judgement to decide whether statistical pooling within these categories was appropriate.

• Short term: up to eight weeks.

• Medium term: between eight and 24 weeks.

• Long term: more than 24 weeks.

Where relevant, we reported outcomes at the latest time point available (assumed to be length of follow-up, if not specified) and the time point specified in the methods as being of primary interest (if this was di erent from the latest time point available).

The primary e ectiveness outcome for this review was ulcer healing. Trialists used a range of di erent methods for measuring and reporting this outcome. RCTs that reported one or more of the following were considered as providing the most relevant and rigorous measures of wound healing.

• Time to complete wound healing (correctly analysed using survival, time-to-event approaches or median (or mean) time to healing, if it was clear that all wounds were healed at follow-up). • Proportion of wounds completely healed during follow-up (frequency of complete healing).

We used the study authors' definitions of complete wound healing, and reported these where possible. Where both the complete wound-healing outcomes above were reported for a study, we presented both and gave precedence to time-to-healing in our interpretation where possible.

The primary safety outcome for the review was all reported adverse events. Where reported, and a clear methodology for the collection of adverse event data had been provided, we extracted data for all serious adverse events and all non-serious adverse events. We preferred to focus on the numbers of participants with adverse events in each study arm; the methodology should make it clear whether events were reported at the participant level or, if multiple events/people were reported, that an appropriate adjustment was made for data clustering.

• Participant health-related quality of life/health status: measured using a standardised generic questionnaire such as EQ-5D (Herdman 2011), SF-36 (Ware 1992), SF-12 (Ware 1996) or SF-6 (Craig 2013), or wound-specific questionnaires such as the Cardi Wound Impact Schedule (Price 2004). We did not include ad hoc measures of quality of life that were not likely to be validated and would not be common to multiple trials. • Cost e ectiveness: within-trial cost-e ectiveness analysis comparing mean di erences in e ects with mean cost di erences between the two arms. Data extracted could be incremental mean cost per incremental gain in benefit (incremental cost-e ectiveness ratio (ICER)). We also extracted other relative cost-e ectiveness measures (e.g. net monetary benefit) and cost analysis findings. • Mean pain score (including pain at dressing change): measured as a continuous outcome using a validated scale such as a visual analogue scale (VAS) or other recognised measurement instrument.

For changes to this section please see Di erences between protocol and review.

We searched the following electronic databases to identify reports of relevant clinical trials:

• We also searched the following trials registries:

• US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (www.clinicaltrials.gov) (searched 30 June 2020); • World Health Organization (WHO) International Clinical Trials Registry Platform (apps.who.int/trialsearch/) (searched 28 August 2019). We could not search this database 30 June 2020 as it was unavailable due to heavy tra ic generated by the COVID-19 situation.

Search strategies for clinical trial registries can be found in Appendix 1.

We identified other potentially eligible trials or ancillary publications by carrying out a search of the reference lists of retrieved included trials, as well as relevant systematic reviews, meta-analyses and clinical practice guidelines for leg ulcers When necessary, we contacted authors of key papers and abstracts to request further information about their trials.

We did not perform a separate search for adverse e ects of interventions used, but considered adverse e ects described in included studies only.

We carried out data collection and analysis according to the methods stated in the published protocol (Shi 2019), which were based on the Cochrane Handbook for Systematic Reviews of Interventions (McKenzie 2021) . Changes from the protocol or previous published versions of the review are documented in Di erences between protocol and review.

Two review authors independently assessed the titles and abstracts of the citations retrieved by the searches for relevance. A er this initial assessment, we obtained full-text copies of all studies considered to be potentially relevant. Two review authors independently checked the full papers for eligibility, with disagreements resolved by discussion and, where required, the input of a third review author. Where the eligibility of a study was unclear we contacted study authors. We recorded all reasons for exclusion of studies for which we obtained full-text copies. We completed a PRISMA flowchart to summarise this process (Liberati 2009).

Where studies were reported in multiple publications or reports, we obtained all publications. Whilst the study was included only once in the review, obtaining all publications maximised the amount of data we extracted. We also examined any relevant retraction statements and errata for information.

We extracted and summarised details of the eligible studies using a data extraction sheet. One review author extracted data and another review author independently checked all data (Di erences between protocol and review). We resolved any disagreements through discussion, consulting a third review author where required. Where data were missing from reports, we contacted the study authors to obtain this information.

Where possible we extracted the following data:

• country of origin;

• trial design (e.g. parallel, cluster);

• study start date and end date;

• study population, including key related medical histories, diagnosis methods, the aetiology of leg ulcers (e.g. postthrombotic syndrome, varicose veins, chronic venous reflux), the onset or recurrence of leg ulcers, and the location of leg ulcers; • care setting;

• eligibility criteria and key baseline participant data (total number of participants, age, sex, duration of leg ulcers, baseline leg ulcer area); • details of the interventions, including compression devices used, and duration of interventions applied; • descriptions of any co-interventions or standard care; • follow-up period;

• unit of randomisation (e.g. leg ulcer, limb, or participant); • numbers of participants randomised to each intervention; • unit of analyses; • number of ulcers per person; • primary and secondary outcomes measured; • data about time to complete wound healing: hazard ratio (HR) and its 95% confidence interval (CI), or any data that will allow its calculation (Parmar 1998; Tierney 2007) ; • data on the proportion of wounds completely healed during follow-up: odds ratio (OR) and its 95% CI, or numbers of participants who have leg ulcers completely healed in each arm, both at the latest time point and (if di erent) at another time specified as of primary interest in the Methods section; • whether a Kaplan Meier plot was displayed; • missing data rates per arm, and reasons for 'missingness', including the number of people who died; • publication status of study; and • source of funding for trial.

Two review authors independently assessed each included study using the Cochrane tool for assessing risk of bias (Higgins 2017). This tool addresses seven specific domains: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete data, selective outcome reporting, and other issues (Di erences between protocol and review). In this review we included unit-of-analysis issues under the domain of 'other issues', for example where a cluster-randomised trial had been undertaken but analysed at the individual level in the study report. We assessed blinding of participants and personnel, blinding of outcome assessment, and incomplete outcome data for each of the review outcomes separately. We note that blinding of participants and personnel as to whether or not participants had been allocated to compression is impossible and therefore performance bias is a risk. Performance bias may be introduced when awareness of treatment allocation results in deviations from intended interventions and/or di erential co-interventions use or care between groups not specified in study protocol which may influence outcomes. We scrutinised study reports and protocols (where available) to understand if, and how, studies attempted to minimise and document protocol deviations and di erential care/co-interventions compensated for this: for example, the study protocol might have been used to highlight the need to balance cointerventions as well as potentially measuring and reporting this.

We assessed risk of bias for each domain as either low risk, high risk or unclear risk. Since wound healing is a subjective outcome, unblinded outcome assessment represents a high risk of bias (Hróbjartsson 2012). We therefore recorded only open intervention studies with blinded outcome assessment as being at low risk of detection bias.

We resolved all disagreements in risk-of-bias assessment by discussion and, where required, we sought the input of a third review author. Where possible, useful and feasible, when a lack of reported information resulted in a judgement of unclear risk of bias, we contacted study authors for clarification. We present our assessment of risk of bias using two risk-of-bias summary figures; one is a summary of bias for each item across all studies, and the second shows a cross-tabulation of each trial by all of the risk-ofbias items. We classified studies with an assessment of high risk of bias for one or more of the seven domains as being at high risk of bias overall for the specified outcome (Di erences between protocol and review).

For trials using cluster randomisation, we planned to consider the risk of bias in relation to: recruitment bias, baseline imbalance, loss of clusters, incorrect analysis and comparability with individuallyrandomised trials (Higgins 2017; Eldridge 2016) (Appendix 2). However, we did not include any studies with a cluster design.

For dichotomous outcomes (e.g. proportion of participants who have wounds completely healed during follow-up), we present the risk ratio (RR) with 95% confidence intervals (CIs). For continuous outcomes we present the mean di erence (MD) with 95% CIs, for trials that used the same assessment scale. If trials that reported continuous data used di erent assessment scales, we present the standardised mean di erence (SMD) with 95% CIs.

Time-to-event data (e.g. time to complete wound healing) are reported as hazard ratios (HRs) where possible, in accordance with the methods described in the Cochrane Handbook for Systematic Reviews of Interventions (Deeks 2021). If studies reporting time-toevent data (e.g. time to healing) did not report a HR, then, when feasible, we estimated this using other reported outcomes (such as numbers of events) through the application of available statistical methods (Parmar 1998; Tierney 2007) . We only considered median time to healing without survival analysis as a valid outcome if reports specified that all leg ulcers had healed (i.e. if the trial authors treated time-to-healing as a continuous measure, as there was no censoring).

We noted whether trials presented outcomes at the level of the leg ulcer, the limb or the participant, and whether there may have been multiple ulcers reported for the same participant. One included study (Kikta 1988) randomised at the participant level and outcomes were measured at the wound level, e.g. leg ulcer healing; we treated the participant as the unit of analysis when the number of leg ulcers assessed appeared to be equal to the number of participants (e.g. one leg ulcer per person).

A particular unit-of-analysis issue may occur in trials if randomisation was carried out at the participant level, with the allocated treatment used on multiple leg ulcers per participant, but data are presented and analysed per leg ulcer (clustered data). We noted whether data for multiple ulcers on a participant were (incorrectly) treated as independent within a study, or were analysed using within-participant analysis methods. If clustered data were incorrectly analysed, we recorded this as part of the risk-of-bias assessment. For an individually-randomised trial, such data on multiple leg ulcers were collected and analysed where applicable:

• only in a proportion of participants; in this case, we only extracted and presented relevant data but did not treat the trial as a cluster trial to seek for an analysis because the trial incorrectly included a mixture of individual and clustered data; or • in all participants; in this case, we planned to treat the trial as a cluster trial and incorporate relevant data in meta-analyses if the trial was analysed correctly. Where a cluster trial was incorrectly analysed, we planned to record this in the risk-of-bias assessment. Where possible we planned to approximate the correct analyses based on guidance in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2021).

Useful information for approximating the correct analyses include:

• the number of clusters randomised to each arm or the average size of each cluster; • the outcome data ignoring the cluster design; and • an estimate of the intracluster correlation coe icient (ICC).

However, we did not include any cluster trials. As noted above, we analysed data that were available in one of three included studies that randomised individual participants but reported data by ulcers (i.e. clustered data).

For cross-over trials, we planned to only consider outcome data at the first intervention phase (i.e. prior to cross-over) as eligible. However, we were not able to obtain such data from the authors of the only cross-over trial included.

It is common for there to be data missing from trial reports. Excluding participants from the analysis post-randomisation or ignoring participants who are lost to follow-up compromises the randomisation and potentially introduces bias into the trial. If we thought that study authors might be able to provide some missing data, we attempted to contact them, but it is likely that data will o en be missing because of loss to follow-up.

In individual studies, when data for the proportion of leg ulcers healed were presented, we assumed that randomly-assigned participants not included in an analysis had an unhealed leg ulcer at the end of the follow-up period (i.e. they were considered in the denominator but not in the numerator). We examined the impact of this assumption through doing a sensitivity analysis (see Sensitivity analysis) in which we assumed participants with missing data had a healed leg ulcer (i.e. they were included in both the numerator and the denominator). When a trial did not specify participant group numbers before dropout, we presented only complete-case data. For the time-to-healing analysis using survival analysis methods, dropouts should be accounted for as censored data. Hence all participants contribute to the analysis. We acknowledged that such analysis assumes that dropouts were missing at random and that there was no pattern of 'missingness'.

We presented data for all categorical secondary outcomes as a complete-case analysis. For continuous secondary outcome variables (i.e. quality of life, pain score), we presented available data from the study reports/study authors and did not impute missing data. We planned to calculate measures of variance when these were missing (Deeks 2021) or we planned to contact study authors, where possible. Where these measures of variation remained unavailable, we planned to exclude the study from any relevant meta-analyses. However, we did not carry out these because all relevant included studies either fully reported the measures of variance or only reported narrative findings.

Assessment of heterogeneity can be a complex, multi-faceted process. Firstly, we considered clinical and methodological heterogeneity, that is the degree to which the included studies varied in terms of participants' characteristics (e.g. mean age, proportion of participants by sex, methods of diagnosing leg ulcers), interventions (e.g. delivery approaches of compression systems), outcome definitions and other characteristics such as duration of follow-up. This assessment of clinical and methodological heterogeneity was supplemented by information about statistical heterogeneity. We assessed statistical heterogeneity using the Chi 2 test (a significance level of P value less than 0.10 was considered to indicate statistically significant heterogeneity) in conjunction with the I 2 measure (Higgins 2003). I 2 examines the percentage of total variation across RCTs that is due to heterogeneity rather than chance (Higgins 2003). Very broadly, we considered that I 2 values of 25% or less did not indicate important heterogeneity, and values of more than 75% indicated considerable heterogeneity (Deeks 2021; Higgins 2003) .

These statistical tests are recognised to be underpowered and should only be used as an indicator of heterogeneity. Clinical, methodological and statistical heterogeneity should therefore be considered together for the overall assessment of heterogeneity. Where there was no clinical or statistical heterogeneity, we used a fixed-e ect model. In the absence of clinical heterogeneity and in the presence of some statistical heterogeneity (I 2 over 50%), we used a random-e ects model; however, we did not anticipate pooling data across studies where heterogeneity was considerable (I 2 over 75%). Where there was evidence of considerable heterogeneity we explored this further if required: see Data synthesis.

Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results. Publication bias is one of a number of possible causes of small-study e ects, that is, a tendency for estimates of the intervention e ect to be more beneficial in smaller RCTs. Funnel plots allow a visual assessment of whether small-study e ects may be present in a meta-analysis. A funnel plot is a simple scatter plot of the intervention e ect estimates from individual RCTs against some measure of each trial's size or precision (Page 2021). Funnel plots are only informative when there are a substantial number of studies included in an analysis; we planned to present funnel plots for meta-analyses that included at least 10 RCTs, using Review Manager 5 (RevMan 2020). However, we did not produce any funnel plots because all the metaanalyses we conducted contained fewer than 10 studies.

We summarised details of included studies in a narrative review according to the comparison between intervention and comparator, the participants, and the outcome measurement including the follow-up duration. We considered clinical and methodological heterogeneity and undertook pooling if studies appeared appropriately similar in terms of participants, intervention comparison, and outcome assessment including follow-up duration. Where studies were not similar enough for pooling, we present the results of included studies narratively.

Once we had decided to pool the results of individual studies, we used a random-e ects approach for meta-analysis. Conducting meta-analysis with a fixed-e ect model in the presence of even minor heterogeneity may provide overly-narrow confidence intervals. We planned to only use a fixed-e ect approach when clinical and methodological heterogeneity was assessed to be minimal, with the assumption that a single underlying treatment e ect was being estimated. We used Chi 2 and I 2 to quantify heterogeneity but not to guide the choice of model for metaanalysis. We exercised caution when meta-analysed data were at risk of small-study e ects, because a random-e ects model may be unsuitable. In this case, or where there were other reasons to question the selection of a fixed-e ect or random-e ects model, we assessed the impact of the approach using sensitivity analyses to compare results from alternate models (Thompson 1999). We reported any evidence that suggested that the use of a particular model might not be robust.

We produced pooled estimates of the treatment e ect using Review Manager 5 (RevMan 2020) and presented data using forest plots where possible. For time-to-event data, we plotted (and, if appropriate, pooled) estimates of HRs and 95% CIs as presented in the study reports, using the generic inverse variance method in Review Manager 5 (RevMan 2020). Where time-to-healing was analysed as a continuous measure, but it was not clear if all wounds healed, we documented use of the outcome in the study, but did not summarise or use the data in any meta-analysis.

We included only the relevant arms where a trial involves multiple arms. If two or more arms in comparison with control were eligible for the same meta-analysis, we pooled data on the two or more arms and compared them with control.

When there appeared to be considerable between-study heterogeneity we planned to explore the causes using the steps proposed by Cipriani 2013:

• check the data extraction and data entry for errors and possible outlying studies; • if outliers existed, perform sensitivity analysis by removing them; and • if heterogeneity was still present, we planned to perform subgroup analyses/meta-regression for study-level characteristics (see below) in order to explain heterogeneity as much as possible (Thompson 1999) .

For subgroup analysis/meta-regression, we considered four studylevel characteristics: funding sources (binary: not-for-profit versus other/unclear); overall risk of bias (binary: low and unclear risk of bias versus high risk of bias); study designs (binary: parallel versus other designs); and follow-up duration (continuous). However, none of our meta-analyses or syntheses included more than 10 studies for a feasible subgroup analysis, so we did not undertake subgroup analysis by any of these factors.

For pooled analyses, where possible, we undertook sensitivity analyses to explore the impact of the following:

• assuming participants with missing data had a healed leg ulcer (i.e. they were included in both the numerator and the denominator) followed by the analysis with the assumption that participants with missing data had unhealed leg ulcers; • removing unpublished data (i.e. abstracts and dissertations) from the analysis; • changing e ects model (i.e. using random-e ects model for the main analysis, followed by a repeated analysis with a fixed-e ect model); and • removing clustered data from the analysis.

We presented the main results of the review in summary-of-findings tables. These tables present key information about the certainty of the evidence, the magnitude of the e ects of the interventions examined and the sum of available data for the main outcomes (Schünemann 2021).

We present the following outcomes in the summary-of-findings tables:

• time to complete wound healing when analysed using appropriate survival analysis methods; • proportion of wounds completely healed during the trial period; • all reported adverse events;

• participant health-related quality of life/health status; • cost e ectiveness; • mean pain score (Di erences between protocol and review).

We used the principle of the GRADE approach to assess the certainty of the body of evidence associated with all outcomes (see Quality of the evidence). The GRADE approach defines the certainty of a body of evidence for the extent to which one can be confident that an estimate of e ect or association is close to the true quantity of specific interest. The assessment of the certainty of a body of evidence using the GRADE approach involves consideration of within-trial risk of bias (methodological quality), directness of evidence, heterogeneity, precision of e ect estimates and risk of publication bias (Schünemann 2021). The certainty of evidence can be assessed as being high, moderate, low or very low; RCT evidence has the potential to be high certainty.

When making decisions about methodological quality, we downgraded our assessment of the certainty of the evidence only when studies were classed as being at an overall high risk of bias. We did not downgrade for assessments of unclear overall risk of bias unless an outcome finding had unclear risk of bias in all domains, where we considered it as being at high overall risk of bias.

In assessing the precision of e ect estimates we followed GRADE guidance using the combination of optimal information size (OIS), and the 95% CIs of e ect estimates:

• if the OIS criterion was not met, downgraded for imprecision, unless the sample size was very large (at least 2000, and perhaps 4000, participants); • if the OIS criterion was met and the 95% CI excluded no e ect (i.e. the CI around the RR excludes 1.0), did not downgrade for imprecision; and • if the OIS criterion was met, and the 95% CI overlapped no e ect (i.e. CI includes RR of 1.0) downgraded for imprecision if the CI failed to exclude important benefit or important harm (i.e. the 95% CIs included a relative risk reduction or increase of 25% or more).

For binary outcomes, we calculated the OIS on the basis of a relative risk reduction or increase of between 20% and 30%, as outlined in the GRADE Handbook and summarised below.

• Time to wound healing: OIS = 524 participants for a reduction in hazard of time to healing of 25% (with 100 days' recruitment and 100 days' follow-up: 80% power; alpha 5% and median time to healing in control group of 90 days). • Proportion of wounds healed: OIS = 308 participants for an increased relative risk of wound healing of 25% (80% power; alpha 5%; proportion healed in control group = 45.08%). • All reported adverse events: OIS = 295 participants for a decreased relative risk of adverse events of 25% (80% power; alpha 5%; proportion reported adverse events in control group = 45%).

For continuous outcomes, we used the rule-of-thumb threshold (OIS = 400) suggested by Schünemann 2013.

We considered downgrading twice for imprecision when, in addition to the rules above, the number of outcome events was considered to be low.

When assessing the remaining domains, we followed GRADE guidance (Schünemann 2013). Where data were not pooled we presented GRADE assessments for the above outcomes narratively in a summary-of-findings table (Murad 2017).

Trusted evidence. Informed decisions. Better health.

Cochrane Database of Systematic Reviews

See Characteristics of included studies; Characteristics of excluded studies; and Characteristics of studies awaiting classification.

The electronic searches identified 2052 records, including 1849 from electronic databases and 203 from trial registries. We excluded 139 duplicate records and screened 1913 records, of which we identified 252 as potentially eligible and obtained them in full-text. Following full-text screening we considered 31 records of 13 studies to be eligible for inclusion in this review (Cardoso 2019; Charles 1991; Daróczy 2006; Eriksson 1984a; Kikta 1988; Morrell 1998; O'Brien 2003; Rubin 1990; Taradaj 2007; Taylor 1998; Wong 2008a; Wong 2008b; Wong 2012) .

From other resources, we identified Groenewald 1984 by scanning the reference list of Kikta 1988.

In total we include 14 studies (with 32 publications) in this review, of which Wong 2008a and Wong 2008b were from the same doctoral thesis: Wong 2008a was a feasibility study and Wong 2008b was the associated full trial. See Figure 1 . 14 Library Trusted evidence. Informed decisions. Better health.

Of the 14 included studies (all RCTs) 13 had a parallel-group design (Charles 1991; Daróczy 2006; Eriksson 1984a; Groenewald 1984; Kikta 1988; Morrell 1998; O'Brien 2003; Rubin 1990; Taradaj 2007; Taylor 1998; Wong 2008a; Wong 2008b; Wong 2012) , and Cardoso 2019 applied a cross-over design.

Ten of the 14 studies used individual participants as the unit of randomisation and analysis (Daróczy 2006; Eriksson 1984a; Groenewald 1984; Morrell 1998; O'Brien 2003; Rubin 1990; Taylor 1998; Wong 2008a; Wong 2008b; Wong 2012) ; one appeared to use legs as the unit of randomisation (i.e. randomising legs a ected by venous ulcers into di erent study arms) and analysed outcome data by ulcers (Cardoso 2019) ; and three appeared to have individuals as the unit of randomisation but ulcers as the unit of analysis (Charles 1991; Kikta 1988; Taradaj 2007 In the 14 studies the median follow-up duration was 12 weeks (range: one day to 12 months).

The 14 studies enrolled a total of 1391 participants with venous leg ulcers (median study sample size: 51 participants; range: 11 to 321). Across the eight studies that specified participant sex (Cardoso 2019; Morrell 1998; O'Brien 2003; Taradaj 2007; Taylor 1998; Wong 2008a; Wong 2008b; Wong 2012) , 526 (50.1%) of participants were male and 524 (49.9%) were female. The average participant age was specified in 11 studies, with a median of 70.1 years (range: 58.0 to 76.5 years ) (Cardoso 2019; Charles 1991; Daróczy 2006; Eriksson 1984a; Morrell 1998; O'Brien 2003; Taradaj 2007; Taylor 1998; Wong 2008a; Wong 2008b; Wong 2012) .

Of the 14 studies, 12 (917 participants) described their participants as those with leg ulcers and with some markers of a venous aetiology, in terms of either a history or clinical evidence of chronic venous disease or a confirmed chronic venous insu iciency, or both (Cardoso 2019; Daróczy 2006; Kikta 1988; O'Brien 2003; Taradaj 2007; Wong 2008a; Wong 2008b; Wong 2012) ; having an ankle pressure/brachial pressure ratio (APBI) greater than 0.8 (Charles 1991; Morrell 1998; O'Brien 2003; Rubin 1990; Taylor 1998; Wong 2008a; Wong 2008b; Wong 2012) or 0.9 (Taradaj 2007). The two remaining studies described their participants as people with venous leg ulcers but did not specify the aetiology of leg ulcers or APBI value (Eriksson 1984a; Groenewald 1984) .

Of the 14 studies, nine reported the average duration of leg ulcers at baseline; the median was 22.0 months (range: 9.0 weeks to 31.6 months) (Charles 1991; Groenewald 1984; Kikta 1988; Morrell 1998; O'Brien 2003; Taradaj 2007; Wong 2008a; Wong 2008b; Wong 2012 (Charles 1991; Morrell 1998) ; and two studies (85 participants) with ulcers larger than 20 cm 2 (Rubin 1990; Taradaj 2007).

Care settings were specified for 10 studies: two recruited participants from hospitals (Cardoso 2019; Taradaj 2007) ; one from an outpatient setting (Groenewald 1984); and seven from community settings (Charles 1991; Morrell 1998; O'Brien 2003; Taylor 1998; Wong 2008a; Wong 2008b; Wong 2012) .

Compression bandages or stockings (including the duration of applying compression and the frequency of changes) and comparators evaluated in the 14 studies are listed in Table 1 Seven studies specified co-interventions they applied (e.g. specific dressings) (Charles 1991; Groenewald 1984; Kikta 1988; Rubin 1990;  

We excluded 130 studies (with 179 records). The main reasons for exclusions were: irrelevant and ineligible interventions (e.g. comparisons of dressings, comparisons of two or more compression bandages or stockings; 126 studies); ineligible study design (e.g. non-RCT; 3 studies); and ineligible participants (one study). We also identified 13 duplicates in screening full texts (see Figure 1 ).

We did not identify any ongoing studies.

We identified five studies (five records) that we could not classify as being eligible or not, as we were unable to obtain the fulltext versions despite extensive e orts, in part due to more limited access to intra-library loans during the COVID-19 period (Cherry 1990; Jünger 2008; Kuznetsov 2009; Robinson 1988; Stacey 2000) .

Random sequence generation (selection bias) Allocation concealment (selection bias) Blinding of participants and personnel (performance bias): All outcomes Blinding of outcome assessment (detection bias): All outcomes Incomplete outcome data (attrition bias): All outcomes Selective reporting (reporting bias) Other bias 0% 25% 50% 75% 100%

Low risk of bias Unclear risk of bias High risk of bias

We judged four of the 14 studies to have an unclear overall risk of bias for the primary outcome (Cardoso 2019; Morrell 1998; O'Brien 2003; Rubin 1990) . We judged the remaining 10 studies as having findings at high overall risk of bias.

Of the 14 studies, four used appropriate methods to generate the random sequence and were judged to have low risk of selection bias (O'Brien 2003; Taylor 1998; Wong 2008b; Wong 2012) . The remaining 10 studies did not adequately describe the randomisation methods.

Of the 14 studies, only Morrell 1998 was judged to have low risk of selection bias due to allocation concealment, because serially-numbered, sealed, opaque allocation envelopes were used to adequately conceal allocation. The remaining 13 studies had an unclear risk of bias judgement due to the lack of relevant information.

Five of the 14 studies were judged as being at high risk of performance bias for the leg-ulcer healing outcome because they clearly stated that the blinding of participants and personnel was di icult to implement or was not implemented (Eriksson 1984a; Groenewald 1984; Wong 2008a; Wong 2008b; Wong 2012) ; and it was unclear if attempts were made to mitigate the risk. The remaining nine studies did not give su icient information for judging if their risk of performance bias was high or low.

We judged six of the 14 studies to have low risk of detection bias for leg-ulcer healing outcome (Eriksson 1984a; Groenewald 1984; O'Brien 2003; Taylor 1998; Wong 2008b; Wong 2012) : all six studies applied devices to measure leg ulcer areas reliably, or involved independent outcome assessors for outcome measurement, or both. The remaining eight studies did not give su icient information for judging if their risk of detection bias was high or low.

Of the 14 studies, Taylor 1998 was judged to have high risk of attrition bias for the leg-ulcer healing outcome because there was a high proportion of dropouts and intention-to-treat (ITT) analysis was not performed. We rated eight studies at low risk of attrition bias (Daróczy 2006; Kikta 1988; Morrell 1998; O'Brien 2003; Rubin 1990; Wong 2008a; Wong 2008b; Wong 2012) : all had low attrition rates (or no attrition), or ITT analysis was performed, or both. The remaining five studies had an unclear risk of bias judgement.

We judged four of the 14 studies to be at high risk of reporting bias (Daróczy 2006; Kikta 1988; Wong 2008a; Wong 2012) . The feasibility study by Wong 2008a measured multiple outcomes but only reported week-12 ulcer-healing outcome data. There were two publications for the Wong 2012 study, with one retracted by the corresponding journal; but the retracted publication appeared to contain a specific outcome that was not included in the unretracted publication. Charles 1991 and Morrell 1998 were judged as being at unclear risk of reporting bias and the remaining eight studies appeared to be free of this bias.

Of the 14 studies, we rated three at high risk of other bias because they used individuals as the unit of randomisation but leg ulcers as the unit of analysis (Charles 1991; Kikta 1988; Taradaj 2007) . We judged Wong 2008a to be at unclear risk of other bias. We judged all the remaining studies to be free of other bias.

See: Summary of findings 1 Compression bandages or stockings compared with no compression for treating venous leg ulcers See Summary of findings 1.

Unless otherwise stated we used a random-e ects analysis throughout; each pooled result presented is an average e ect, rather than a common e ect, and should be interpreted as such.

All 14 studies assessed this comparison, of which Cardoso 2019 did not report analysable data for any outcomes.

Time-to-complete wound healing (follow-up period one day to 12 months) analysable data from Daróczy 2006 and Taylor 1998. We pooled time-to-event data from five studies (733 participants: Kikta 1988; Morrell 1998; O'Brien 2003; Taylor 1998; Wong 2008b) . Note that Wong 2008b reported a multivariable analysis adjusted for covariates (age, initial ulcer size, and ulcer duration). Kikta 1988 contained clustered data (participants randomised but outcome data reported on multiple ulcers for some participants); as the number of ulcers (87 ulcers) was close to the number of participants (n = 84) ulcer-level data were included here. The pooled hazard ratio (HR) for healing is 2.17 (95% confidence interval (CI) 1.52 to 3.10; I 2 = 59%; Analysis 1.1).

Moderate-certainty evidence suggests there is probably a shorter time to complete healing of venous leg ulcers in people wearing compression bandages or stockings compared with those not wearing compression. We downgraded the evidence across the five studies once for risk of bias (one study with clustered data and another small study were at high overall risk of bias in domains other than performance bias, and the other three studies with most of the data in this synthesis were at unclear overall risk of bias).

As noted above, these studies are heterogeneous in terms of unit of analysis, care setting, follow-up durations, risk of bias, and compression therapies applied. However, we did not perform any prespecified subgroup analysis because there are fewer than 10 studies.

• Sensitivity analysis of removing unpublished data (i.e. abstracts and dissertations) . When the doctoral thesis Wong 2008b was removed from the data analysis, the evidence remained consistent with the main analysis (Appendix 4). • Sensitivity analysis with fixed-e ect rather than randome ects model . The use of a fixed-e ect model resulted in no change in e ect estimates. The evidence remained consistent with the main analysis (Appendix 4).

Kikta 1988 was removed, the result remained consistent with the main analysis (Appendix 4).

Ten studies (1215 participants) reported this outcome (Charles 1991 Of the remaining two studies (95 participants) without analysable data, Charles 1991 reported that 71% of leg ulcers completely healed in short-stretch bandages and 25% in usual care. Daróczy 2006 reported that 82% of 21 participants with ulcers healed when using compression plus local povidone-iodine (Betadine) and 62% of 21 participants with ulcers healed when using local povidoneiodine (Betadine).

Across the 10 studies, there is moderate-certainty evidence that people treated with compression bandages or stockings probably have more completely-healed venous leg ulcers during follow-up to 12 months than people not using compression. We downgraded the certainty of the evidence once for risk of bias (of the 10 studies, six with 569/1215 (46.8%) participants were at high risk of bias in the domains other than performance bias and the other four were at unclear risk of bias in some but not all domains).

The studies are heterogeneous in terms of unit of analysis, care setting, follow-up duration, risk of bias, and compression therapies applied and there was some statistical heterogeneity (Chi 2 test P value = 0.006; Tau 2 = 0.06; I 2 = 65%). As noted in Subgroup analysis and investigation of heterogeneity, we removed an extreme value (Morrell 1998) and found that once it was removed, I 2 went from 65% to 0% (Chi 2 test P value = 0.51; Tau 2 = 0.00; I 2 = 0%) but the pooled RR of 1.94 (95% CI 1.67 to 2.26) remained consistent with Analysis 1.2 and still favoured the use of compression bandages or stockings. Morrell 1998 is notably di erent from the other studies, in that 53% of 3433 participant visits in the control arm involved provision of compression whilst the control arms of other studies either did not deliver compression or only delivered for a small proportion of participants. We did not perform any prespecified subgroup analysis because there are fewer than 10 included studies in Analysis 1.2.

• Sensitivity analysis of considering participants with missing data as having unhealed leg ulcers . Four of the eight studies in Analysis 1.2 had missing data (Kikta 1988; Taylor 1998; Wong 2008a; Wong 2008b) . The main analysis was not sensitive to considering participants with missing data as having unhealed ulcers (Appendix 4).

. The main analysis was not sensitive to the removal of the doctoral theses Wong 2008a; Wong 2008b from Analysis 1.2 (Appendix 4). • Sensitivity analysis with a fixed-e ect rather than randome ects model . The main analysis was not sensitive to application of a fixed-e ect model (Appendix 4).

Kikta 1988 was removed, the result remained consistent with the main analysis (Appendix 4).

Ten studies reported adverse events (Eriksson 1984a; Groenewald 1984; Kikta 1988; Morrell 1998; O'Brien 2003; Rubin 1990; Taylor 1998; Wong 2008a; Wong 2008b; Wong 2012) . See Table 2 Cochrane Database of Systematic Reviews removing Kikta 1988 that reported clustered data resulted in a pooled RR of 1.60 (95% CI 0.74 to 3.43; I 2 = 40%).

It is uncertain whether there is any di erence in the risk of adverse events associated with using compression and not using compression. Evidence is of very low certainty, downgraded once for risk of bias (two studies with the larger numbers of participants were at high risk of bias in some domains and one study contributing 30.6% of the weight was at unclear risk of bias), twice for substantial inconsistency, as the clustered data were inconsistent with the data reported by participant, and once for imprecision because the CIs appeared to include the possibility of both benefit and harm as well as no e ect. All data reported in these studies are summarised in Table 3 . We pooled data from two studies (426 participants with available data; Wong 2008b; Wong 2012; Analysis 1.4). The MD in the total score of the Charing Cross Venous Ulcer Questionnaire (lower scores = better quality of life) is −6.87 (95% CI −13.10 to −0.64) between using compression bandages or stockings and no compression, which favours the use of compression bandages or stockings. However, Analysis 1.4 showed no di erence in the physical component, mental component, and functional status of the SF-12 (higher scores = better quality of life).

Of the two studies that had no analysable data, Morrell 1998 (233 participants) stated that, for most dimensions of the SF-36 and EuroQol, health status deteriorated over time but was not di erent between four-layer bandages and usual care. O'Brien 2003 (200 participants) reported a statistical di erence, favouring the use of compression bandages or stockings, in some dimensions of the SF-36 (including physical function, role-physical, mental health) and the disease-specific quality of life instrument for chronic lower limb venous insu iciency (CIVIQ) (physical, social, and global dimensions), but not in others.

Overall, low-certainty evidence suggests that compression bandages or stockings may improve participant health-related quality of life in some (but not all) aspects during the follow-up of 12 weeks to 12 months in comparison with no compression. We downgraded the certainty of the evidence twice for substantial inconsistency due to the variation in the reported results, particularly for health status.

Three studies (486 participants) reported this outcome (Charles 1991; Morrell 1998; O'Brien 2003) , but we were unable to pool their data.

Without reporting any data, Charles 1991 (53 participants) noted that the short-stretch bandage was more cost-e ective than usual care, as it could be washed and reused repeatedly. Morrell 1998 (233 participants) reported an incremental cost-e ectiveness ratio of GBP 2.46 (95% CI −31.94 to 99.12) per ulcer-free week (1995 prices) associated with using the four-layer bandage in leg-ulcer clinics compared with no compression delivered outside the clinic setting. Using a cost analysis, O'Brien 2003 (200 participants) reported that the median cost per leg healed was significantly less for four-layer bandages than for dressings (P = 0.04).

It is uncertain whether compression bandages or stockings are cost-e ective compared with no compression in wound healing. Evidence is of very low certainty, downgraded once for risk of bias (one small study was at high overall risk of bias in domains other than performance bias, and the other two studies were at unclear risk of bias in some domains), once for indirectness (the outcomes in Charles 1991 and O'Brien 2003 did not appear to be expressed as incremental mean cost per incremental gain in benefit), and once for inconsistency in cost-e ectiveness results between studies.

Mean pain score (median follow-up period 12 weeks minimum 12 weeks maximum 12 months)

Six studies (1048 participants) reported this outcome, and varied in the way they measured pain (Kikta 1988; Morrell 1998; O'Brien 2003; Wong 2008a; Wong 2008b; Wong 2012) . All data reported in the included studies are summarised in Table 4 .

Of the six studies, Wong 2008a did not report endpoint outcome data. We pooled data from three studies with analysable data: two (426 participants having available data) reported data by participant (Wong 2008b; Wong 2012), whilst Kikta 1988 reported ulcer-level (clustered) data (69 ulcers with available data) and the ulcer-level data were included here. The analysis showed people using compression bandages or stockings had a lower mean pain score than those using no compression (i.e. dressings) (MD −1.39, 95% CI −1.79 to −0.98; Analysis 1.5). A post hoc sensitivity analysis removing Kikta 1988 that reported clustered data resulted in a pooled MD of −1.48 (95% CI −2.05 to −0.91; I 2 = 29%).

Of the other two studies that did not report analysable data, Morrell 1998 (233 participants) stated that people treated with four-layer bandages were more likely to experience a reduction in leg ulcer pain per month than those using usual care; and O'Brien 2003 (200 participants) reported a lower median of pain scores among those using four-layer bandages than those using dressings (median 18.8, IQR 6.3 to 37.5; and 31.3, 18.8 to 43.8, respectively; P = 0.14).

Moderate-certainty evidence suggests the use of compression probably reduces mean pain score compared with no compression. Across the five studies with data or results synthesised, we downgraded the evidence certainty once for risk of bias, as two studies with 345 participants were at high overall risk of bias.

We report a review of 14 RCTs on the e ects of compression compared with no compression on the healing of venous leg ulcers. Compression bandages and stockings used in the included studies varied and some study reports did not adequately define the compression. The most frequently used systems were short-stretch bandages, four-layer compression and Unna's boot. The no-compression comparators also varied across the included studies and included 'usual care' where no details were specified, pharmacological treatment, a variety of dressings, and Cochrane Database of Systematic Reviews a wide variety of treatments where some participants received compression (but it was not the norm).

There is moderate-certainty evidence that there is probably a shorter time to complete healing of venous leg ulcers in people wearing compression bandages or stockings compared with those not wearing compression over a 12-month follow-up (five studies with 733 participants); and that people treated with compression bandages or stockings probably have more completely healed venous leg ulcers during follow-up to 12 months than people not using compression (10 studies with 1215 participants). It is uncertain whether there is any di erence in adverse e ect rates between using compression bandages or stockings and no compression (three studies with 585 participants; very lowcertainty evidence).

Moderate-certainty evidence suggests that the use of compression bandages or stockings probably reduces pain compared with no compression (five studies with 859 participants and 69 ulcers in other participants).

There is low-certainty evidence that compression bandages or stockings versus no compression may improve disease-specific quality of life but not all aspects of general health status during the follow-up of 12 weeks to 12 months (four studies with 859 participants).

There is uncertainty as to whether use of compression bandages or stockings is more cost-e ective than not using them (three studies with 486 participants).

As a result of the extensive literature searches, we consider that this review covers all potential RCT evidence on compression bandages or stockings versus no compression for healing venous leg ulcers. However, there are limitations in the completeness and applicability of the evidence identified.

Whilst compression bandages and stockings are widely used, data on the e ects of compression bandages or stockings on ulcer healing are sparse for the numbers of studies and participants, and the duration of follow-up: 14 studies included in this review enrolled a total of 1391 participants, with a median study sample size of 51 participants (range: 11 to 321). Only four studies enrolled more than 100 participants and they together accounted for 67% (934/1391) of the participants; they were all from community settings that were most represented in the review. Three of these four studies were conducted in more than one research site. The duration of follow-up was relatively short, with a median follow-up duration of 12 weeks.

Participants included in the studies had average ages ranging from 58.0 to 76.5 years. The included studies all described their participants as having venous leg ulcers, but only 66% (917/1391) of participants had leg ulcers with a clearly-specified aetiology (a history or clinical evidence of chronic venous disease, the confirmed cause of chronic venous insu iciency, or both), or had an APBI of greater than 0.8 or 0.9. The duration of leg ulcers amongst study participants had a median of 22.0 months (range: 9.0 weeks to 31.6 months). The average baseline area of leg ulcers amongst study participants also varied: three studies had participants with an average ulcer size of less than 5 cm 2 ; four had ulcers between 5 and 10 cm 2 ; two had ulcers between 10 and 20 cm 2 ; and two had ulcers larger than 20 cm 2 .

Participants were recruited from community or outpatient settings and most were from high-income and upper-middle-income economies.

Studies included in this review used a range of compression bandages or stockings, including elastic short-stretch bandages (five studies); four-layer bandage including the Charing Cross bandaging technique (six studies); and Unna's boot (five studies). There were no studies of systems such as inelastic paste systems, e.g. Setocrepe, or two-component bandage systems e.g. 3M Coban 2 Compression System.

The magnitude of sub-bandage resting pressure applied varied between studies: only seven included studies specified the pressure applied for 854 participants (minimum 18 mmHg, maximum 50 mmHg; i.e. moderate or high compression according to Thomas 1995) .

Another limitation in the included studies was the variation in comparators applied, including medications (two studies), usual care from community nurses (three studies); and dressings (nine studies). Importantly, in three studies, participants in the nocompression groups could receive compression (Morrell 1998; O'Brien 2003; Taylor 1998) , and one small study (Eriksson 1984a) replaced the dressings comparator with compression bandages during the study period.

Whilst this review included a total of 14 studies, there is a very limited evidence base on adverse e ects, participant health-related quality of life, and cost e ectiveness.

We note that we did not synthesise evidence on the outcome of participant adherence to compression treatment, as we initially planned, because this outcome was only relevant to the compression arm of these studies. Also, studies aiming to evaluate ulcer healing can only provide observational data for the ulcer recurrence outcome. We therefore did not consider evidence on ulcer recurrence as an outcome in this review, as we had initially planned.

We assessed the certainty of evidence for all six outcomes using GRADE. We report our assessment results in Summary of findings 1, where we present the number of studies and the number of participants contributing to evidence synthesis. Evidence from two of the six syntheses was of very low certainty, one was of low certainty and three were of moderate certainty. Our downgrading was largely due to high overall risk of bias, and inconsistency across the studies.

We downgraded once for five of the six evidence syntheses for overall risk of bias. When judging overall risk of bias, we considered all domains. However, in assessing evidence certainty, we acknowledge that the blinding of participants and personnel is impractical for the comparison of compression bandages or stockings versus no compression and did not downgrade for this Cochrane Database of Systematic Reviews blinding. We judged that 10 of the 14 studies were at high overall risk of bias and seven of the 10 studies were at high risk of bias in domains other than blinding of participants and personnel.

We considered all the evidence to be direct (and so did not downgrade), except that two of the three studies included in coste ectiveness evidence synthesis appeared to report cost analyses rather than full cost-e ectiveness evaluations, which express cost e ectiveness as incremental mean cost per incremental gain in benefit, or vice versa.

We downgraded for inconsistency for three evidence syntheses, largely because we found statistical heterogeneity in these syntheses or inconsistency of reported results between studies. The three outcomes this relates to are adverse events, health-related quality of life, and cost e ectiveness.

Note that none of these meta-analyses or syntheses included more than 10 studies for a feasible subgroup analysis; so, despite the fact that we found heterogeneity by unit of analysis, overall risk of bias, care settings, follow-up durations, or compression therapies applied between the included studies, we only considered the unitof-analysis factor in our evidence syntheses, but did not consider other factors for subgroup analysis.

We only downgraded for imprecision for the adverse event synthesis, as the numbers of participants included in other metaanalyses or syntheses were more than our estimated optimal information size (OIS). The downgrading for adverse events was due to the wide confidence intervals in the data analysis.

We did not downgrade for publication bias because firstly we have confidence in the comprehensiveness of our literature searches, and secondly we did not find any clear evidence of non-reporting bias of study results. Although we planned to produce funnel plots for meta-analysis to visually inspect for publication bias, there was no analysis including more than 10 studies.

We followed prespecified methods to review evidence in order to prevent potential bias in the review process. We ran comprehensive electronic searches, searched trial registries, and checked references of included studies and systematic reviews identified in electronic searches. We also contacted study authors of four studies (Cardoso 2019; Wong 2008a; Wong 2008b; Wong 2012) to clarify details. We included a study that had one retracted publication (Wong 2012).

This review also has limitations. Firstly, we did not consider the di erences between specific compression bandages or stockings: four-layer compression, Unna's boot and short-stretch bandages were covered by the generic term of compression bandages or stockings. Similarly, the di erence between specific comparators was not considered in this review. Because of these, heterogeneity between studies in this review was inevitable. However, because of the limited number of included studies, we did not undertake subgroup analysis by the types of specific compression bandages or stockings or specific comparators. Secondly, for all of the six outcomes in this review, the included studies measured outcomes di erently, or reported outcome data in ways that could not be meta-analysed. For example, of the seven studies which included data for the 'Time to complete wound healing' outcome, we were only able to pool data for five studies (Analysis 1.1). We therefore did not undertake or rely on any single meta-analysis in summarising the findings and assessing the certainty of evidence. We reviewed all studies included for any outcome and assessed the certainty of evidence using the approach described in Murad 2017. Thirdly, in terms of the data on time to complete wound healing, we estimated the HRs and CIs for two studies included in Analysis 1.1 (Kikta 1988; Taylor 1998) using the methods described in Tierney 2007, whilst recognising that those calculated data (and the associated metaanalysis) might be inaccurate. We noted that the time-to-event data analysis using the HRs and CIs we calculated appeared to agree with associated binary data analyses, as we expected.

Our electronic searches identified three systematic reviews or meta-analyses ( Pain is a common complication experienced by people a ected by venous leg ulcers. Although application of compression may cause pain temporarily, ulcer-related pain can be chronic. This review has identified new evidence that the use of compression bandages and stockings probably reduces pain compared with no compression.

Our review also found evidence, albeit uncertain, on the cost e ectiveness of using compression bandages and stockings.

People with venous leg ulcers who wear compression bandages or stockings probably experience wound healing more quickly, and more people are likely to experience complete ulcer healing than people who do not wear compression. This is moderate-certainty Cochrane Database of Systematic Reviews evidence, meaning that the true e ect is likely to be close to the reported estimate of the e ect in this review. Risk of bias of some of the included studies resulted in downgrading of the certainty of evidence. The use of compression bandages or stockings probably reduces pain and may improve disease-specific quality of life. However, uncertainty remains about the relative risks of adverse e ects, and the cost e ectiveness of compression bandages or stockings versus no compression.

In many countries, compression bandages and stockings have become essential components of care for people with venous leg ulcers. Future research should focus on identifying the most e ective and acceptable ways of delivering compression. Future studies should collect and analyse data on adverse events and cost e ectiveness, and should explore whether certain modes of compression are associated with more patient adherence and greater acceptability.

Limitations in the existing evidence are due to studies with small sample sizes and suboptimal RCT designs. Given that the baseline prevalence of venous leg ulcers is not high and most people with this condition stay in community settings, future research can be conducted in multiple research sites and should carefully consider sample size calculations. Over-estimation of event rates that fail to occur can lead to imprecision and less robust e ect estimates.

Future studies should also consider carefully the choice of outcomes they report; time-to-event data for complete wound healing should be used in trials. Careful and consistent assessment and reporting of adverse events including pain score need to be undertaken. Further studies should aim to collect and report health-related quality of life using validated measures and should include cost-e ectiveness analysis where possible. Participant adherence to compression bandages or stockings may be key to successful wound healing and should be considered in any future research.

Any future trials must be undertaken to the highest standard possible. Whilst it is challenging to avoid the risk of performance bias in trials of compression devices, where applicable, strictly implementing a standardised intervention plan can help to minimise risk. It is also important to ensure that protocols mandate balanced use of co-interventions (e.g. dressings) across trial arms. Follow-up periods should be for as long as possible, and clinically relevant in di erent settings. 

Random sequence generation (selection bias)

Unclear risk Quote: "The order of events considering the use of Unna's boot and traditional dressing was randomly assigned by chance and drawing a number from an envelope determined the type of dressing to be used until the next evaluation."

Comment: unclear risk of bias because the method of generating random numbers is not clear

Unclear risk Quote: "The order of events considering the use of Unna's boot and traditional dressing was randomly assigned by chance and drawing a number from an envelope determined the type of dressing to be used until the next evaluation."

Blinding of participants and personnel (performance bias) All outcomes

Unclear 

• Not reported • Notes: these outcome data were not available. However, the short-stretch bandage is claimed to be "cost effective, as it retains its elasticity despite being washed and reused repeatedly."

• Not reported

Outcomes that are not considered in this review but reported in trials:

• Pressure measurements • Proportions of leg ulcers with a reduction in size of more than half • Leg circumference Identification Publication type/ status (e.g. conference abstract): full paper (Charles 1991); short report (Charles 1992 (see Charles 1991))

Source of funding: not described; Lohmann UK, Stone, Aylesbury supplying the bandages, padding and the use of an Oxford monitor for this project

Comments: the authors stated this paper was part of a research project submitted to the Parkside Health Authority (the project report was not obtained)

Random sequence generation (selection bias) Unclear risk Quote: "Patients with an ankle pressure index < 0.8 were randomly divided into a control and an experimental group" Comment: unclear risk of bias because of the lack of information on random number generation Allocation concealment (selection bias)

Blinding of participants and personnel (performance bias) All outcomes

Blinding of outcome assessment (detection bias) All outcomes

Incomplete outcome data (attrition bias) 

Interventions

Porcine skin dressing Eriksson 1984a presented results of 2 trials: the 2-week trial 1 compared 0.9% sodium chloride in sterile water with dextranomer beads through randomising 53 participants with venous leg ulcers and 9 patients excluded because of ulcer healing or reasons unrelated to the trial 2 prior to the conduct of trial 2. With the remaining 44 participants, trial 2 was undertaken to compare 2 dressing methods with a compression bandage method. Only data from trial 2 were extracted for this review

Random sequence generation (selection bias) 

Duration of leg ulcers: some with recent onset; most with more than 6 months and some for many years

Group difference: not given

Unit of randomisation (e.g. leg ulcer, limb, or participant): participants

Hydrocolloid dressings 

• Not reported

• Notes: "Few unfavourable effects were recorded during the trial in the patients treated with hydrocolloid dressings." "An increased tendency toward fungus infections was noted in some cases treated with hydrocolloid dressings." 7 of 36 withdrew in hydrocolloid dressing due to non-compliance (n = 2) and treatment stopped (n = 5 including 2 having pain and irritation and 3 with overwhelming sepsis); 6 of 36 withdrew in compression bandage due to treatment changes required (overwhelming sepsis and ulcer size increase)

Cost effectiveness

Mean pain score

Outcomes that are not considered in this review but reported in trials:

• Reduction in ulcer size presented as the outcome measure. Mean reduction in ulcer size of 67.64% in hydrocolloid dressing and 22.62% in compression bandage (P < 0.0001; SE = 3.51) • Participant adherence to compression treatment. This outcome is not measured using a prespecified method. 7 of 36 withdrew in hydrocolloid dressing due to non-compliance (n = 2) and treatment stopped (n = 5 including 2 having pain and irritation and 3 with overwhelming sepsis); 6 of 36 withdrew in compression bandage due to treatment changes required (overwhelming sepsis and ulcer size increase)

Publication type/ status (e.g. conference abstract): full paper Group difference: no statistically significant differences between groups in many variables (e.g. age; sex; race; type of previous ulcer treatment; pre-randomisation use of antibiotics; origin of chronic venous insufficiency; the incidence of previous venous, arterial, or orthopaedic operations; prior use of elastic stockings; the incidence of ischaemic heart disease, congestive heart failure, diabetes mellitus, hypertension, pulmonary, renal, and hepatic diseases; the use of oral contraceptives or tobacco; the presence of obesity or alcoholism; elevated levels of serum haemoglobin, glucose, albumin, and creatinine; whether the ulcer was new or recurrent; ABIs; and PPG-VRT) 

• Proportion of wounds completely healed or improved during follow-up • Participants self-reported convenience of using either intervention (rated using a linear scale with grades from 1 to 10; 1 = most convenient) • Participants self-reported ease of change (rated using a linear scale with grades from 1 to 10; 1 = easiest to change)

Publication type/ status (e.g. conference abstract): full paper 

• Patient satisfaction (Collins 1997) 

• Outcome type: binary • Time points: 12 weeks • Data and results (including summary results, or any data that will allow its calculation): 1 died in 4LB but information not reported in control group. • Notes: this outcome is unlikely measured using a prespecified method. Cochrane Database of Systematic Reviews

• Reporting: partially reported • Measurement method (e.g. scale, self-reporting): participants interviewed and disease-specific quality-of-life instrument for chronic lower limb venous insufficiency (CIVIO) used. CIVIO has the domain of pain (lower overall score = better quality of life) • Definition: pain measured in CIVIO • Missing data and reasons (including the number of people who died): questionnaires completed for 92.9% (79/85) and 95.8% (91/95) participants who remained unhealed at 6 weeks in 4LB and control groups (missing data for the rest of participants because of their unhealing) • Notes: 12-week data not collected.

Outcomes that are not considered in this review but reported in trials:

• Mean reduction in ulcer size. 

Random sequence generation (selection bias) Low risk Quote: "… a random 'intervention' or 'control' list was generated for 200 patients by computer …" Comment: low risk of bias because of the use of a proper randomisation method Allocation concealment (selection bias) Unclear risk Quote: "Before the study began, a random 'intervention' or 'control' list was generated for 200 patients by computer, and the results were entered sequentially into sealed numbered envelopes. These envelopes were assigned to consecutive patients once consent had been obtained"

Comment: unclear risk of bias because they do not describe if envelopes are opaque

Blinding of participants and personnel (performance bias) All outcomes

Blinding of outcome assessment (detection bias) All outcomes 

Random sequence generation (selection bias) Unclear risk Quote: "Each patient was randomised by the study coordinator to either a PFD or Unna boot dressing treatment protocol."

Comment: unclear risk of bias because the method of random-sequence generation is not specified Allocation concealment (selection bias)

Unclear risk Quote: "The study coordinator did not see the randomization card and was therefore blinded as to the treatment cohort"

Comment: unclear risk of bias because it is unclear if allocation is concealed so that investigators cannot foresee assignment of participants Blinding of participants and personnel (performance bias) All outcomes

Blinding of outcome assessment (detection bias) All outcomes

Unclear risk Comment: no information provided on who/how outcomes were assessed Incomplete outcome data (attrition bias) All outcomes Low risk Outcome: complete wound healing Quote: "9 (52.9%) of 17 participants of group 1 withdrew from the study due to wound odor" Outcomes that are not considered in this review but reported in trials:

• Change of ulcer length in relation to baseline • Change of ulcer width in relation to baseline • Change of ulcer field in relation to baseline • Change of granulation surface area in relation to baseline

Publication type/ status (e.g. conference abstract): full paper (Polish)

Source of funding: not described

Comments: ultrasound therapy plus pharmacological treatments were used as a third group in this trial. Data for this group were not extracted for this review, given it was not eligible Random sequence generation (selection bias)

Unclear risk Comment: unclear risk of bias because randomisation method is not specified. From translator: "... random assignment ..."

Allocation concealment (selection bias)

Unclear risk Comment: no information provided

Blinding of participants and personnel (performance bias) All outcomes

Unclear risk Comment: no information provided

Blinding of outcome assessment (detection bias) All outcomes

Unclear risk Comment: no information provided Incomplete outcome data (attrition bias) All outcomes

Unclear risk Comment: no information provided Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were prespecified

Other bias High risk Comment: high risk of bias because the unit of randomisation was participants but the unit of analysis was probably leg ulcers

Methods Study objective: to compare healing rates and associated treatment costs of 4-layer high-compression bandaging and conventional management in the treatment of venous leg ulcers prior to treatment and 1 with treatment postponed due to scabies) in compression; 4 exclusions (1 died, 1 healed naturally before treatment, 1 treated with 4-layer high compression bandage, 1 developed cellulitis and required prolonged hospitalisation) in conventional.

• Outcomes that are not considered in this review but reported in trials:

• Number of visits.

Publication type/ status (e.g. conference abstract): full paper (Taylor 1998), 2 conference abstracts probably not measured using a prespecified method • Definition: total numbers of participants with adverse events • Notes: the study authors reported hospitalisation due to medical conditions as a reason of withdrawals but did not consider it as adverse events (see Table 12 of Wong 2008b). The review authors did not extract relevant data here. 

Random sequence generation (selection bias) Low risk Quote: "Eligible patients were randomly assigned to either one of the experimental groups or the control group by a random list ... A randomisation list with three treatment blocks was generated by a computer program before the study ..."

Comment: low risk of bias because of the use of a proper method of generating random sequence.

Unclear risk Quote: "The participants were allowed to open the envelope for grouping allocation only after the collection of baseline data. The patients were not informed whether they were assigned to an intervention or control group until the completion of the study. The strength of this allocation concealment in random trials ..."

Comment: unclear risk of bias because information provided is insufficient for this domain's judgement Blinding of participants and personnel (performance bias) All outcomes

High risk Outcome group: all outcomes Quote: "participants and interviewers (data collectors) were not informed of the treatment allocation of the study participants for the duration of the study"

Quote: "the interveners who performed wound dressing and/or bandaging were not blinded to the treatment groups. Blinding the interveners is not achievable ..."

Blinding of outcome assessment (detection bias) All outcomes Low risk Outcome group: ulcer healing and pain outcomes Quote: "This was a double-blind study, in which the interviewers who were responsible for the pre-test and post test data collections were not given any information regarding the group to which the participant was assigned"

Quote: "The data collector then received the electronic file periodically and performed the perimeter tracing and area calculation using the Wound Mea- Eligibility criteria: inclusion of either men or women aged 55 years or older having confirmed venous leg ulcers (with partial or full-thickness skin loss) by clinical and vascular assessment (i.e. Doppler); without necrotic tissue; ability to understand and communicate in Cantonese; ABPI ≥ 0.8 indicating suitability for compression bandaging. Exclusion of people with ulcers of < 5 cm 2 or > 118 cm 2 , with an ulcer duration of less than 4 weeks or longer than 1 year; those with 2 or multiple leg ulcers, either on 1 or both legs; those with an ABPI < 0.8 and those with concurrent administration of drugs that may affect ulcer healing, such as corticosteroids or chemotherapeutics Videometer) to assess reduction in ulcer area • Definition: ulcer healing within 6 months • Missing data and reasons (including the number of people who died): all included in analysis.

• Outcome type: binary • Time points: not described • Measurement method (e.g. scale, self-reporting): probably not measured using a prespecified method • Definition: total numbers of participants with adverse events • Notes: data on dropouts due to reasons other than adverse events were not extracted for this review.

Data extracted for this review were based on Table 5 of Wong 2012 rather than its Figure 1 that had different numbers of dropouts due to adverse events. 

(1) The study reported clustered data but the participant was treated as the unit of analysis as the number of ulcers (n = 87) ≈ the number of participants (n = 84)

Compression unspecified

Undefined compression plus local povidone-iodine (Betadine)

Local povidone-iodine (Betadine) -

Short-stretch compression bandages (Rosidal, with the spiral technique and 1 -3 times of changes per week) that was expected to achieve mean pressure of 33 mmHg 

Four-layer bandage following the Charing Cross bandaging technique (with a weekly treatment)

• Compression levels and the duration of application unspecified A wide variety of treatments applied without restriction other than the use of high-compression bandaging -

Four-layer bandage (Profore)

• Sub-bandage resting pressure between 40 and 50 mmHg changed weekly for 24 weeks A variety of dressings -

Four-layer bandage (Profore)

• Sub-bandage resting pressure between 40 and 50 mmHg changed weekly for 24 weeks A variety of dressings -

Four-layer bandage (Profore)

• Sub-bandage resting pressure between 40 and 50 mmHg changed weekly for 24 weeks Based on descriptions of compression therapies, the review authors considered the compression used was Unna's boots.

Eriksson 1984a replaced porcine skin dressings -due to its unavailability -with double-layer bandage #2 ((varicose next ulcer*) or (venous next ulcer*) or (leg next ulcer*) or (stasis next ulcer*) or (crural next ulcer*) or (ulcus next cruris) or (ulcer* next cruris)):ti,ab,kw S35 S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 S20 TI (randomised OR randomized) S19 MH cluster sample S18 MH pretest-posttest design S17 MH random assignment S16 MH single-blind studies S15 MH double-blind studies S14 MH randomized controlled trials S13 S3 AND S12 S12 S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 S11 TI wrapp* OR AB wrap Cochrane Database of Systematic Reviews S10 TI bandag* OR AB bandag* S9 TI ( sock or socks or tights ) OR AB ( sock or socks or tights ) S8 TI ( stocking* or hosiery ) OR AB ( stocking* or hosiery ) S7 TI compression* OR AB compression* S6 (MH "Elastic Bandages") S5 (MH "Compression Therapy") S4 (MH "Compression Garments") S3 S1 OR S2 S2 TI ( ((varicose ulcer*) or (venous ulcer*) or (leg ulcer*) or (stasis ulcer*) or (crural ulcer*) or (ulcus cruris) or (ulcer* cruris)) ) OR AB ( ((varicose ulcer*) or (venous ulcer*) or (leg ulcer*) or (stasis ulcer*) or (crural ulcer*) or (ulcus cruris) or (ulcer* cruris)) ) S1 (MH "Leg Ulcer+") Appendix 2. Risk of bias 1 Risk-of-bias assessment (individually randomised controlled trials)

The investigators describe a random component in the sequence generation process such as: referring to a random number table; using a computer random number generator; coin tossing; shu ling cards or envelopes; throwing dice; drawing of lots.

Trusted evidence. Informed decisions. Better health.

• For continuous outcome data, plausible e ect size (di erence in means or standardised di erence in means) among missing outcomes not enough to have a clinically-relevant impact on observed e ect size. • Missing data have been imputed using appropriate methods.

Any one of the following.

• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups. • For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinicallyrelevant bias in intervention e ect estimate. • For continuous outcome data, plausible e ect size (di erence in means or standardised di erence in means) among missing outcomes enough to induce clinically-relevant bias in observed e ect size. • 'As-treated' analysis done with substantial departure of the intervention received from that assigned at randomisation.

• Potentially inappropriate application of simple imputation.

Any one of the following.

• Insu icient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated, no reasons for missing data provided). • The study did not address this outcome.

Any of the following.

• The study protocol is available and all of the study's prespecified (primary and secondary) outcomes that are of interest in the review have been reported in the prespecified way. • The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were prespecified (convincing text of this nature may be uncommon).

Any one of the following.

• Not all of the study's prespecified primary outcomes have been reported.

• One or more primary outcomes are reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not prespecified. • One or more reported primary outcomes were not prespecified (unless clear justification for their reporting is provided, such as an unexpected adverse e ect). • One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.

• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.

Insu icient information to permit judgement of low or high risk of bias. It is likely that most studies will fall into this category.

The study appears to be free of other sources of bias.

There is at least one important risk of bias. For example, the study:

• had a potential source of bias related to the specific study design used; or • has been claimed to have been fraudulent; or • had some other problem. both reporting a higher proportion of leg ulcers completed healed when using compression bandages or stockings than using no compression

• Sensitivity analysis of removing unpublished data (i.e. abstracts and dissertations) 8 1005

• 6 studies (910 participants) with data reported by participants: RR 1.57 (95% CI 1.24 to 1.99; I 2 = 50%) • 2 studies (95 participants) without analysable data:

both reporting a higher proportion of leg ulcers completed healed when using compression bandages or stockings than using no compression

• Sensitivity analysis using a fixed-effect model 10 1215

• 8 studies (1120 participants) with data reported by participant: RR 1.75 (95% CI 1.54 to 1.98; I 2 = 65%) • 2 studies (95 participants) without analysable data:

both reporting a higher proportion of leg ulcers completed healed when using compression bandages or stockings than using no compression

• Post hoc sensitivity analysis of removing clustered data 9 1131

• 7 studies (1036 participants) with analysable data:pooled RR 1.79 (95%CI 1.38 to 2.33; I 2 = 70%) • 2 studies (95 participants) without analysable data:

both reporting a higher proportion of leg ulcers completed healed when using compression bandages or stockings than using no compression 

Chunhu Shi: designed the review; co-ordinated the review; extracted data; analysed or interpreted data; undertook quality assessment; performed statistical analysis; produced the first dra of the review; contributed to writing or editing the review; wrote to study authors/ experts/companies; approved the final review prior to publication.

Jo Dumville: conceived the review; designed the review; co-ordinated the review; analysed or interpreted data; checked quality of statistical analysis; contributed to writing or editing the review; advised on the review; performed previous work that was the foundation of the current review; approved the final review prior to publication.

Nicky Cullum: conceived the review; designed the review; checked quality of statistical analysis; contributed to writing or editing the review; advised on the review; performed previous work that was the foundation of the current review; approved the final review prior to publication.

Emma Connaughton: checked quality of data extraction; undertook quality assessment; checked quality assessment; contributed to writing or editing the review; approved the final review prior to publication.

Using bioelectrical impedance analysis to compare the treatment of edema with the Unna's boot and noncompression in individuals with venous ulcers

*:ti,ab,kw #6 stocking* or hosiery:ti,ab,kw #7 sock or socks or tights:ti,ab,kw #8 bandag*:ti,ab,kw #9 wrapp*:ti,ab

Copyright © 2021 The Authors

$ or match or matched or allocation) adj5 (alternate or group$1 orintervention$1 or patient$1 or subject$1 or participant $1)).ti,ab. 28 (assigned or allocated).ti,ab. Compression bandages or stockings versus no compression for treating venous leg ulcers

Copyright © 2021 The Authors

Editor): edited the protocol of this review; advised on methodology, interpretation and content

Managing Editor): co-ordinated the editorial process

Information Specialist): designed the search strategy and edited the search methods section

former Editorial Assistant): edited the reference section of the protocol of this review

Editorial Assistant): edited the reference section of the review

Chunhu Shi: I received support from the Tissue Viability Society to attend conferences unrelated to this work. The Doctoral Scholar Awards Scholarship and Doctoral Academy Conference Support Fund (University of Manchester) also supported a PhD and conference attendance respectively

Dumville: this research was co-funded by the National Institute for Health Research Manchester Biomedical Research Centre, and partly funded by the National Institute for Health Research Applied Research Collaboration Greater Manchester

this research was co-funded by the National Institute for Health Research Manchester Biomedical Research Centre, and partly funded by the National Institute for Health Research Applied Research Collaboration Greater Manchester

My previous and current employers received research grant funding from the NHS Research and Development programme and the Health Technology Assessment Programme for systematic reviews on compression, and for two randomised controlled trials of compression. These RCTs were not eligible for inclusion in this review

Emma Connaughton: none known

peer reviewer for the protocol for this review) declares that one of the review authors was the Head of the department in which he works, although he himself is not involved with the wound care research team within this department and has not been involved with the preparation or writing of this review

Ineligible intervention 

Random sequence generation (selection bias)

Quote: "Eligible patients were randomly assigned to either one of the experimental groups (compression treatment) or the control group using a computer generated list after pre-test measurements were taken" Comment: low risk of bias because of the use of a proper method of generating random sequence Allocation concealment (selection bias) Unclear risk Quote: "After confirming eligibility of a patient and obtaining informed consent, the clinical investigator digitally received the information on the allocation of the patient to one of the treatment groups" [based on retracted paper].Comment: unclear risk of bias because information provided is insufficient for this domain's judgement Blinding of participants and personnel (performance bias) All outcomesHigh risk Outcome group: all outcomes Quote: "participants and interviewers (data collectors) were not informed of the treatment allocation of the study participants for the duration of the study" (Wong 2008b) Quote: "the interveners who performed wound dressing and/or bandaging were not blinded to the treatment groups. Blinding the interveners is not achievable ..." (Wong 2008b) Comment: high risk of bias because in our judgement it is clearly not possible to blind either participants or personnel and a related study (Wong 2008b) suggest that there is non-blinding of participantsBlinding of outcome assessment (detection bias) All outcomes 

Adverse events in no compression Inference

No case abandoned;No symptoms of peripheral arterial circulatory insufficiency 6 participants stopped using Metallina(R) aluminium foil dressing earlier because of poor effect (ulcer size increase or infections, or both)

Groenewald 1984 6 of 36 withdrew due to treatment changes required (overwhelming sepsis and ulcer size increase) 7 of 36 withdrew in hydrocolloid dressing due to non-compliance (n = 2) and treatment stopped (n = 5 including 2 having pain and irritation and 3 with overwhelming sepsis);Few unfavourable effects recorded for those using hydrocolloid dressings;An increased tendency toward fungus infections noted in some cases treated with hydrocolloid dressings 

Cochrane Database of Systematic Reviews

The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.

Insu icient information about the sequence generation process to permit judgement of low or high risk of bias.

Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation); sequentially-numbered drug containers of identical appearance; sequentially-numbered, opaque, sealed envelopes.

Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on: using an open random-allocation schedule (e.g. a list of random numbers); assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non-opaque or not sequentially numbered); alternation or rotation; date of birth; case record number; any other explicitly unconcealed procedure.

Insu icient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not described or not described in su icient detail to allow a definite judgement, for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.

Any one of the following.• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by lack of blinding. • Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of others unlikely to introduce bias.

Any one of the following.• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.

Any one of the following.• Insu icient information to permit judgement of low or high risk of bias.• The study did not address this outcome.

Any one of the following.• No missing outcome data.• Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias).• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinicallyrelevant impact on the intervention e ect estimate.There may be a risk of bias, but there is either:• insu icient information to assess whether an important risk of bias exists; or • insu icient rationale or evidence that an identified problem will introduce bias 2 Risk-of-bias assessment (cluster-randomised controlled trials)

Recruitment bias (or identification bias) is the bias that occurs in cluster-RCTs if the personnel recruiting participants know individuals' allocation, even when the allocation of clusters has been concealed appropriately. The knowledge of the allocation of clusters may lead to bias because the individuals' recruitment in cluster trials is o en behind the clusters' allocation to di erent interventions; and the knowledge of allocation can determine whether individuals are recruited selectively.This bias can be judged through considering the following questions.• Were all the individual participants identified/recruited before randomisation of clusters?• Is it likely that selection of participants was a ected by knowledge of the intervention?• Were there baseline imbalances that suggest di erential identification or recruitment of individual participants between arms?

Baseline imbalance between intervention groups can occur due to chance, problems with randomisation, or identification/recruitment bias. The issue of recruitment bias has been considered above.In terms of study design, the risk of chance baseline imbalance can be reduced by the use of stratified or pair-matched randomisation. Minimisation -an equivalent technique to randomisation -can be used to achieve better balance in cluster characteristics between intervention groups if there is a small number of clusters.Concern about the influence of baseline imbalance can be reduced if trials report the baseline comparability of clusters, or statistical adjustment for baseline characteristics.

Similar to missing outcome data in individually-randomised trials, bias can occur if clusters are completely lost from a cluster trial, and are omitted from the analysis.The amount of missing data, the reasons for missingness and the way of analysing data given the missingness should be considered in assessing the possibility of bias.

Data analyses which do not take the clustering into account, in cluster trials will be incorrect. Such analyses lead to a 'unit of analysis error' and over-precise results (too small standard error) and too small P values. Although these analyses will not result in biased estimates of e ect, if not correctly adjusted they will lead to too much weight allocated to cluster trials in a meta-analysis.Note that the issue of analysis may not lead to concern any more and will not be considered substantial if approximate methods are used by review authors to address clustering in data analysis.

In the case that a meta-analysis includes, for example, both cluster-and individually-randomised trials, potential di erences in the intervention e ects between di erent trial designs should be considered. This is because the 'contamination' of intervention e ects may occur in cluster-randomised trials, which would lead to underestimates of e ect. The contamination could be known as a 'herd e ect', i.e. within clusters, individuals' compliance with using an intervention may be enhanced, which in turn a ects the estimation of e ect. Regarding the proportion of wounds completely healed, the difference in the data is due to the different assumptions applied for data analysis (see Sensitivity analysis). No statistical difference in the preand post-treatment changes of total surface area, volume, length, width, field, and granulation surface area among groups (P-values of all between-group comparisons > 0.05); the percentage of weekly wound surface change rates; and the percentage of weekly ulcer volume change rates. 

• We deleted the outcomes 'ulcer recurrence' and 'participant adherence to compression treatment', as the comparison of recurrence rates a er initial healing is observational and the adherence outcome was only relevant to the compression arm of the included studies. • We applied the trial filter developed by Glanville 2019 for the CINAHL Plus search, prepared by the Cochrane Centralised Search Service (CSS), rather than the Scottish Intercollegiate Guidelines Network (SIGN 2019) filter documented in the protocol. • We involved one review author for independent data extraction and another review author to double-check.• We assessed risk of bias in included studies using the tool with seven specific domains that separated the blinding of participants and personnel from blinding of outcome assessment, rather than a tool with six domains that considered the two domains of blinding together. • We judged overall risk of bias using all seven domains rather than only three domains (sequence generation, allocation concealment, and blinding of outcome assessment) as pre-planned. • We included mean pain score in our Summary-of-findings table together with the other outcomes listed.